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INTRODUCTION 
Histamine, chemically 5-(2-aminoethyl) imidazole, 
generally known as local hormone or autocoid is the first 
vasoactive amine identified in the body, that is produced 
locally in response to some stimulus1. The H1 histamine 
receptor (H1HR), one of the G protein-coupled receptors 
(GPCRs) mediates the functional effects of histamine in 
the multiple cell types through activation of the Gq/11 
heterotrimeric G protein. These histamine-induced 
intracellular messengers promote diverse functions in 
multiple cell types, including smooth muscle and non 
smooth muscle contraction2,3 and exocytotic release of 
neurotransmitters and various autocrine/paracrine 
factors4,5, both of which can contribute to inflammation 
and inflammatory disease processes6,7. 
Compounds containing thienopyrimidine nucleus represent 
a very important chemical class of antagonists in drug 
discovery due to their wide range of pharmacological 
properties, including antiallergic, anti-inflammatory, 
analgesic, antispasmodic, antibacterial, antifungal etc8. 
Therefore, the interest in developing quantitative structure 
activity relationships (QSAR) for this class of bioactive 
compounds remains high in medicinal chemistry. 
Quantitative structure activity relationship (QSAR) 
modeling is an area of computational research that 
constructs models to correlate structural features with 
biological activity, which provides information that is 
useful for drug design and discovery. The underlying 
assumption is that the variations of biological activity 
within a series of similar structures can be correlated with 
changes in measured or computed molecular features of  
 
the molecules. Therefore, QSAR study remains as a very 
useful tool in the era of modern drug discovery to get 
better insight into structure activity relationships9-12. 
QSAR models are analyzed with various statistical 
parameters to assess reliability and robustness and are 
useful for various purposes like lead optimization, risk 
assessment, toxicity prediction and regulatory decisions, 
including the prediction of activities of untested 
chemicals13. 
To get insight into structure-activity relationship, we have 
developed QSAR models for a series of thieno[2,3-
d]pyrimidin-4(3H)-ones using Genetic Function 
Approximation (GFA) technique that automates the search 
for QSAR models by combining a genetic algorithm with 
statistical modeling tools. Replacing the regression 
analysis with the GFA algorithm allows the construction of 
models competitive with, or superior to, standard 
techniques and makes available additional information not 
provided by other techniques. GFA can build models using 
not only linear polynomials but also higher-order 
polynomials, splines, and Gaussians.          By using spline 
based terms, GFA can perform a form of automatic outlier 
removal and classification. Therefore, GFA technique has 
been successfully applied for the generation of variety of 
QSAR models14,15, such model provides structure-activity 
insights, which can be used for designing of new 
compounds and activity prediction prior to synthesis. The 
goal of this research is to rationalize the title compounds in 
terms of physicochemical and structural requirements for 
enhanced binding affinity to the H1-Histamine receptor 
(H1HR). 
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EXPERIMENTAL 
Data set 
In present study, H1-Histaminic inhibitory activity data of 
a series of thieno [2,3-d]pyrimidin-4(3H)-ones reported by 
Shirsath, V.S. et al., was selected16. The IC50(µM) values, 
were converted to negative logarithmic scale (pIC50) to 
achieve normal distribution, used as dependent variable in 
the QSAR study. Total set of 38 compounds were 
randomly divided into training set and test set of thirty one 
and seven compounds, respectively. Structures of all the 
compounds used for QSAR analysis and their H1-
Histaminic inhibitory activity (IC50 in µM) are given in 
Table 1. Structures of all compounds used in this study 
were sketched by using Visualizer module of Discovery 
studio 2.1 software (Accelrys Inc., USA)17.
Table 1: Chemical structures and biological activity of total data set containing Thienopyrimidine derivatives 
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Compound No.   R IC50 (µM) pIC50 
1 -H 0.37 6.422 
2 -OCH3 0.12 6.906 
3 -OC2H5 0.49 6.308 
4 -F 0.29 6.537 
5 -CH(CH3)2 0.66 6.180 
  6* -CH3 0.20 6.679 
  7* -Br 0.25 6.600 
  8* -Cl 0.21 6.673 
9 -benzylamino 0.49 6.301 
10 -morpholino 0.47 6.321 
11 -H 0.41 6.378 
12 -OCH3 0.39 6.407 
13 -OC2H5 0.58 6.235 
14 -F 0.33 6.473 
15 -Br 0.32 6.485 
16 -Cl 0.30 6.515 
17 -CH(CH3)2 0.64 6.191 
  18* -CH3 0.25 6.586 
19 -H 0.42 6.375 
20 -CH3 0.29 6.531 
21 -F 0.35 6.447 
22 -piperidino 0.39 6.406 
23 -H 0.51 6.290 
Compound No.   R IC50 (µM) pIC50 
 
24 -CH3 0.32 6.482 
25 -OC2H5 0.65 6.181 
26 -Cl 0.38 6.415 
27 -3-CH3 0.62 6.207 
28 -4-Cl 0.59 6.229 
29 -3-CH3,4-Cl 0.42 6.376 
  30* -3,4-CH=CH-CH=CH- 1.80 5.744 
31 -H 0.67 6.173 
32 -4-Cl 0.44 6.356 
33 -3-CH3,4-Cl 0.63 6.200 
  34* -4-CH3 0.79 6.102 
  35* -3,4-CH=CH-CH=CH- 1.05 5.978 
36 -H 0.32 6.494 
37 -CH3 0.36 6.443 
38 -H 0.46 6.337 
Where,   * Compounds in the test set 
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STATISTICAL METHOD 
Regression analysis 
GFA is genetic principle based technique of variable 
selection, which combines Holland’s genetic algorithm 
with Friedman’s multivariate adaptive regression (MARS) 
splines to generate population of equations that best fit the 
training set data18. Employing this technique in QSAR 
analysis, begins with generation of population of equations 
(set at 100 by default in the Discovery studio 2.1 
software), rather than one single equation for correlation 
between the dependent (biological activity) and 
independent variables (descriptors). From this set of 100 
equations, two best models are selected as “parents” and 
genetic crossover operations were performed at random 
and a new model created from each parents. A default 
value of number of crossing over was set at 5000. The 
goodness of each progeny equation is assessed by 
Friedman’s lack of fit (LOF) score, which is given by 
following formula: 
LOF = LSE/[1 – (c + dp)/m]2 
Where LSE is the least square error, c is the number of 
basis functions in the model, d is smoothing parameter, p 
is the numbers of descriptors and m is the number of 
observations in the training set. The smoothing parameter, 
which controls the scoring bias between equations of 
different sizes, was set at default value of 0.5. The length 
of equation was fixed to six terms and, the population size 
was established as 100, the equation term was set to 
quadratic polynomial with spline functionality. The 
statistical qualities of generated models were judged by 
various parameters such as regression coefficient (r), 
adjusted regression coefficient (radj), cross-validated 
regression coefficient (rcv) and F-test values to select best 
equations, from 100 equations. 
Selection of molecular descriptors  
A common practice in building QSAR models is to select 
descriptors, considered as vital element of ligand based 
study, and should not be intercorrelated and show lesser 
degree of multi-collinearity. To develop QSAR models, 
descriptors were selected by analysis of correlation matrix 
and variance inflation factor19. In this study, sixty eight 
molecular descriptors representing electronic, spatial, 
structural, thermodynamic, geometric, topological and 
quantum mechanical properties were calculated using 
calculate molecular properties protocol of the PC based 
software, Discovery Studio 2.1. (Accelrys Inc, USA).  
From the data of correlation matrix, highly correlated 
descriptors with value of 0.9 or above (implying highest 
multicollinearity) and with zero value were removed from 
the study. Remaining descriptors were used to develop 
QSAR models using GFA technique. Descriptors included  
in developing QSAR models are listed and described in 
Table 2. Correlation matrix of descriptors used in the 
QSAR study is given in the Table 3. 
Validation test 
Validation is necessary in QSAR methodology to prove 
that the generated models are acceptable for its intended 
purpose. Statistical significance of the generated QSAR 
models was analyzed by variance inflation factor (VIF) 
analysis, cross validation or internal validation with 
training set and external validation with test data set. 
To check the inter-correlation of descriptors, variance 
inflation factor (VIF) analysis was performed. VIF value is 
calculated from 1/1-r2, where r2 is the multiple correlation 
coefficient of one descriptor’s effect regressed on the 
remaining molecular descriptors. VIF value greater than 
10, implying chance-correlation and hide the information 
of descriptors by inter-correlation and multicollinearity20.
  
To determine the quality of model internally, cross-
validation (CV) techniques are extensively employed and 
is analyzed by the value of correlation coefficient of the 
cross-validation procedure, that is r2cv whose values greater 
than 0.5 indicates robustness and significance for a 
satisfactory QSAR model and it is calculated by following 
formula. 
 
To avoid chance correlation, an ultimate reliable validation 
procedure was carried out and is examined by means of 
external validation in terms of values of residuals, r2pred and 
r2m using test set compounds. The predictive correlation 
coefficient (r2pred) value is based on test set only and is 
defined by the following equation21. 
r
2
pred = (SD – PRESS)/SD 
where, SD is the sum of the squared deviations between 
the biological activities of the test set and mean activity of 
the training set molecules and PRESS is sum of the 
squared deviation between predicted and actual activity 
values for every molecule in the test set. 
Table 2: List of descriptors used in the study 
Sr. 
No. 
Descriptors Type Description 
1 AlogP 98 Thermodynamic Determine the lipophilicity of the molecule. 
2 Dipole_Z, 
Dipole_Y 
Electronic The dipole moment descriptor is a 3D electronic descriptor 
that indicates the strength and orientation behavior of a 
molecule in an electrostatic field. 
3 Jurs_TASA,  Jurs_RPCG Geometric Jurs descriptors combine shape and electronic information 
to characterize molecules. The descriptors calculated by 
mapping atomic partial charges on solvent accessible 
surface areas of individual atoms. 
4 LUMO_Eigenvalue_VAMP, 
Dipole_Mag_VAMP 
Quantum mechanical Energy of the highest and lowest occupied molecular 
orbitals 
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Table 3: Values of the selected descriptors used in the equation1 
 
Compound 
No. 
LUMO_ 
Eigenvalue_ 
VAMP 
Dipole_Mag 
_VAMP 
AlogP 
98 Dipole_Y Dipole_Z Jurs_TASA 
1 -0.788 2.515 3.019 -0.251 -0.008 501.846 
2 -0.926 4.7 3.003 -1.044 0.045 519.657 
3 -0.921 4.383 3.351 -1.091 0.063 562.628 
4 -0.973 5.723 3.224 0.962 -0.171 460.726 
5 -0.913 3.401 4.213 0.069 0.036 564.4 
6 -0.761 1.429 2.748 0.507 0.699 521.636 
7 -0.559 1.333 1.388 -0.515 0.431 449.313 
8 -0.903 4.043 2.267 0.158 0 477.793 
9 -0.896 4.251 2.251 1.807 0 492.607 
10 -0.892 3.943 2.6 1.739 0.003 534.79 
11 -0.952 5.648 2.473 0.911 0.008 445.322 
12 -0.985 5.576 3.016 0.553 0.005 500.57 
13 -0.971 5.508 2.932 0.646 0.006 494.604 
14 -0.895 3.217 3.462 0.251 0.174 544.412 
15 -0.666 0.72 3.511 -0.932 0.088 505.961 
16 -0.648 1.028 3.997 -1.001 0.072 524.841 
17 -0.721 1.589 3.716 -0.043 0.235 470.769 
18 -0.559 1.541 3.109 -0.144 -0.182 511.854 
19 -0.708 0.997 2.759 -0.927 0.112 473.27 
20 -0.687 1.32 3.246 -1.007 0.094 492.967 
21 -0.685 1.479 3.092 0.308 -1.01 515.571 
22 -0.778 1.357 3.424 -0.328 0.256 492.071 
23 -0.615 1.908 3.68 -0.829 -2.08 519.869 
24 -0.696 0.651 3.858 -0.068 -1.79 510.932 
25 -0.677 0.799 4.344 -0.095 -1.702 538.511 
26 -0.834 2.215 2.442 -0.16 -1.417 450.885 
27 -0.898 2.871 3.107 0.423 -1.431 480.366 
28 -0.888 2.589 3.593 0.333 -1.54 501.892 
29 -1.994 8.335 2.121 -0.944 2.273 485.733 
30 -1.581 6.973 2.608 1.819 3.376 523.705 
31 -2.099 7.523 1.37 -2.267 1.809 488.407 
 
To better understand the external predictability of models, modified correlation coefficient (r2m) is determined by the 
following equation22. 
r2m  =  r
2[1-│√(r2-r0
2)│] 
where, r2 is the squared correlation coefficient between observed and predicted values and r20  is the squared correlation 
coefficient between observed and predicted values without intercept. 
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Table 4: Correlation matrix of the descriptors used in the equation 
  AlogP 98 LUMO 
Eigen_ 
VAMP 
Dipole_ 
Mag_ 
VAMP 
Dipole_
Y 
Dipole_
Z 
Jurs_ 
RNCG 
Jurs_ 
TASA 
AlogP 98 1       
LUMO_Eigen_ 
VAMP 
0.49 1      
Dipole_Mag_ 
VAMP 
-0.49 -0.75 1     
Dipole_Y -0.009 0.10 0.17 1    
Dipole_Z -0.50 -0.67 0.60 0.004 1   
Jurs_RNCG -0.18 0.06 -0.29 -0.216 -0.309 1  
Jurs_TASA 0.54 0.05 -0.09 -0.012 -0.015 -0.20 1 
 
RESULT AND DISCUSSION 
In the present study, 32 preselected descriptors from 
correlation matrix were correlated with training set using 
GFA technique. Initially, 100 QSAR equations with six 
descriptors were generated. For a statistically significant 
model, it is necessary that the descriptors evolved in the 
equation should not be inter-correlated with each other, 
and the value was found very low in the selected models. 
Results of the best five models with six parameters as per 
the rule of ‘per descriptors five compounds’, which 
showed acceptable statistical characteristics are shown in 
Table 5. 
Table 5: Selected QSAR equation and their regression statistics 
Equation 
No. 
Equations 
1.    pIC50= 5.9926 + 0.0854929 * Dipole_Z + 0.0172095 * AlogP 98 * AlogP 98 + 0.101165 * 
<Dipole_Mag_VAMP − 1.90968> − 0.0136121 * <Jurs_TASA − 531.927> + 0.121374 * 
<1.28239 − Dipole_Y>−0.691162*<−0.925744− LUMO_Eigenvalue_VAMP> 
2.    pIC50= 5.8776 + 0.0923629 * AlogP 98 + 0.0815622 * Dipole_Z + 0.0988983 * <Dipole_Mag_VAMP 
− 1.95464> − 0.0128245 * <Jurs_TASA − 532.858> + 0.122882 * <1.28239 − Dipole_Y> − 
0.662946 * <−0.925744 − LUMO_Eigenvalue_VAMP> 
Equation 
No. 
Equations 
3.    pIC50= 5.98837 + 0.11172 * AlogP 98 + 0.0935328 * Dipole_Z− 3.91047 * Jurs_RPCG * Jurs_RPCG 
+ 0.0843938 * <Dipole_Mag_VAMP − 1.90968> − 0.0123058 * <Jurs_TASA − 529.42> + 
0.111195 * <0.850262 − Dipole_Y> 
4.    pIC50= 6.18475 + 0.125322 * AlogP 98 + 0.103095 * Dipole_Z− 2.2012 * Jurs_RPCG + 0.0760798 * 
<Dipole_Mag_VAMP − 1.46901> − 0.0126567 * <Jurs_TASA − 528.754>+ 0.108086 * 
<0.925883 − Dipole_Y> 
5.    pIC50= 6.06119 + 0.0915044 * Dipole_Z + 0.0182142 * AlogP 98 * AlogP 98 + 0.0859676 * 
<Dipole_Mag_VAMP − 1.90968> − 5.11642 * <Jurs_RPCG − 0.299467>− 0.012167 * 
<Jurs_TASA − 529.926> + 0.115156 * <0.744643 − Dipole_Y> 
 
Table 6: Statistical parameters of the generated equations 
Equation No. LOF r
2
 r
2
 adj r
2
 cv F Value 
1 0.030 0.771 0.714 0.611 13.53 
2 0.031 0.759 0.699 0.588 12.62 
3 0.032 0.756 0.695 0.560 12.40 
4 0.032 0.755 0.693 0.554 12.33 
5 0.032 0.753 0.692 0.575 12.25 
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Table 7: Summary of external validation parameters 
Equation no. r
2
pred r2m 
1 0.726 0.561 
2 0.712 0.575 
3 0.714 0.511 
4 0.706 0.510 
5 0.714 0.508 
To check the inter-correlation of descriptors, variance 
inflation factor analysis was performed. The VIF values of 
descriptors of best models included in the QSAR study 
was found to be   1.64 (Dipole_Z), 1.37 (AlogP 98), 2.38 
(Dipole_Mag_VAMP), 5.75 (Jurs_TASA),              5.04 
(LUMO_Eigenvalue_VAMP) and 2.12 (Dipole_Y). All 
the VIF values were found to be less than 10, indicates low 
inter-correlation of the descriptors used in the selected 
models. The molecular descriptors selected after 5000 
generations performed by GFA, rejecting highly correlated 
descriptors, used to generate QSAR models, and affected 
the biological activity are shown in the Histogram (Figure 
1). 
 
Figure 1: Histogram of molecular descriptors used in generation of models. 
The models were also evaluated for their predictive power, 
i.e. internal and external cross-validation. Model 1 is 
considered to be the best based on both validation 
parameters. The results for the Equation 1 are summarized 
in Table 6 & 7. The regression correlation coefficient (r2) 
of 0.77 shows good correlation with biological activity, 
cross-validation coefficient (r2cv) of 0.61 indicates good 
internal predictability, predicted correlation coefficient 
(r2pred) of 0.73 and mean correlation coefficient (r
2
m) value 
of 0.56 indicates reliability and significance of the model 
as external validity parameters. Each equation is assessed 
by Friedman’s lack of fit (LOF) and F-value. 
Values of observed activity and predicted activity of 
training set and test set compounds was found to be very 
close, as evident from the values of residual (Table 8 and 
9), which indicates robustness of models and also the 
power to predict the activity of related compounds. Figure 
2 and 3 depicts the plot of observed vs predicted activity 
for training and test set compounds, respectively as per 
equation 1.  
QSAR study of the thienopyrimidine series showed 
thermodynamic, electronic and geometric descriptors, and 
were found to have significant influence on the inhibition 
activity of H1-receptor antagonists as exemplified from 
high value of their coefficients. AlogP 98 is 
thermodynamic descriptor which computes the 
lipophilicity of the molecule. All models   (Table 5) shows 
that lipophilicity has positive contribution towards 
biological activity. Jurs descriptors are a group of 
molecular descriptors which combine shape and electronic 
information to characterize molecules. These descriptors 
are calculated by mapping atomic partial charges on 
solvent-accessible surface areas of individual atoms. 
Jurs_TASA is total atomic surface area, calculated by total 
atomic charged surface areas divided by the total 
molecular solvent-accessible surface area. A critical 
analysis of all equations showed negative contribution of 
these descriptors on biological activity. This means that the 
charge distribution within the molecules acts as the driving 
force for intermolecular interactions and the lesser the 
relative charge the larger the interactions. This suggests 
that molecules with less bulkier and more lipophilic 
substituents are more likely to show activity. The above 
fact is exemplified from compounds, 2 (R = -OCH3), 6 (R 
= -CH3), 7 (R = -Br) and 8 (R = -Cl) where lesser values of 
the Jurs descriptors resulted in increase in activity. 
Notably, the most potent compound 2 has a very less value 
of this descriptor signifying the effect of these geometric 
descriptors on biological activity. 
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Table 8: Observed and predicted pIC50 values of training set compounds (as per equation 1) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 9: Observed and predicted pIC50 values of test set compounds (as per equation 1) 
Compound     
No. 
Observed 
activity 
Predicted 
activity 
Residuals 
1 6.679 6.514 0.165 
2 6.600 6.644 -0.043 
3 6.673 6.624 0.049 
4 6.586 6.424 0.162 
5 5.744 6.027 -0.282 
6 6.102 6.241 -0.138 
7 5.978 6.281 -0.302 
 
 
Figure 2:  Plot of observed Vs predicted pIC50 values of training set compounds (as per equation 1) 
Compound No. Observed Activity Predicted Activity Residuals 
1 6.423 6.395 -0.028 
2 6.907 6.721 -0.186 
3 6.308 6.316 0.008 
4 6.538 6.545 0.007 
5 6.18 6.157 -0.023 
6 6.31 6.268 -0.042 
7 6.321 6.277 -0.044 
8 6.379 6.43 0.051 
9 6.408 6.333 -0.075 
10 6.236 6.283 0.047 
11 6.474 6.497 0.023 
12 6.485 6.565 0.08 
13 6.516 6.547 0.031 
14 6.192 6.291 0.099 
15 6.376 6.484 0.108 
16 6.532 6.555 0.023 
17 6.447 6.409 -0.038 
18 6.407 6.315 -0.092 
19 6.291 6.402 0.111 
20 6.483 6.462 -0.021 
21 6.182 6.187 0.005 
22 6.416 6.411 -0.005 
23 6.208 6.312 0.104 
24 6.229 6.263 0.034 
25 6.377 6.245 -0.127 
26 6.174 6.18 0.006 
27 6.357 6.237 -0.12 
28 6.201 6.267 0.066 
29 6.495 6.441 -0.054 
30 6.444 6.466 0.022 
31 6.337 6.368 0.031 
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Figure 3: Plot of observed Vs predicted pIC50 values of test set compounds (as per equation 1) 
The dipole moment descriptor is a 3D electronic descriptor 
that indicates the strength and orientation behavior of a 
molecule in an electrostatic field. Dipole_Y and Dipole_Z 
electronic descriptor which represents dipole moment of 
molecule in Y and Z dimension respectively, positive 
values of its coefficient indicates that as dipole moment 
increase in this Y and Z dimension respectively, activity 
increases. Moreover, its higher coefficient value was found 
among all descriptors. This indicates that dipole moment is 
the important descriptors that significantly influence the 
H1-Histaminic inhibitory activity.  
Another set of descriptors, quantum mechanical viz., 
LUMO_Eigenvalue_VAMP and Dipole_Mag_VAMP, 
describes the energy of the highest and lowest occupied 
molecular orbitals showed significant contribution in 
biological activity being having high value of their 
coefficients.  
In consistent with the above correlation, the 3D Point plot 
shown in Figure 4, describes that the less bulky and 
lipophilic-electronic substituents are likely to increase the 
biological activity of the similar molecules and as expected 
were found to be potent H1-Histaminic  inhibitors.  
 
Figure 4: 3D Point plot of most influencing molecular descriptors used in generation of QSAR models. 
CONCLUSION 
The established QSAR models were found to be statistically 
significant as evidenced from their regression statistics that 
shows significant correlative and predictive ability in terms 
of good q2 and r2 values. Very low residuals were obtained 
in internal and external validation methods suggest that 
developed models are predictive. Moreover, the good r
2
pred 
and r2m values for an external test set, conﬁrms the excellent 
predictive ability of the established QSAR model. 
Thermodynamic, electronic and geometric descriptors were 
found to be important descriptors which described H1-
Histaminic inhibitiory property of thieno[2,3-d]pyrimidin-
4(3H)-ones series. Results indicated that potency can be 
enhanced by emphasizing on more lipophilic, less bulkier 
substitutents as well as on electrostatic potential of 
compounds as it is evident from their physicochemical 
properties. These results may provide valuable guidance for 
improving the biological activity of the analogs and 
continuing search for potent H1-Histaminic inhibitors prior 
to synthesis. 
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